n-formylmethionine leucyl-phenylalanine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayssas, M; Blaise, D; Fossat, C; Juhan-Vague, I; Maraninchi, D; Sainty, D; Stoppa, AM; Viens, P; Yver, A | 1 |
| Ambrogi, F; Angiolini, C; Azzarà, A; Carulli, G; Minnucci, S; Sbrana, S | 1 |
| Buthmann, U; Freund, M; Kleine, HD; Volk, J | 1 |
2 trial(s) available for n-formylmethionine leucyl-phenylalanine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
In vivo stimulation of neutrophil function by lenograstim (glycosylated rHuG-CSF) in oncohematologic patients: results of a phase I trial.
Topics: Adult; Cell Adhesion; Chemotaxis, Leukocyte; Female; Granulocyte Colony-Stimulating Factor; Granulocytes; Hodgkin Disease; Humans; In Vitro Techniques; Lenograstim; Leukocyte Count; Leukocyte Elastase; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Muramidase; N-Formylmethionine Leucyl-Phenylalanine; Neoplasms; Neutrophils; Pancreatic Elastase; Phagocytosis; Recombinant Proteins | 1994 |
fMLP-induced CD11b/CD18 upregulation on neutrophils from patients with non-Hodgkin's lymphomas treated with recombinant human granulocyte colony-stimulating factor.
Topics: Adult; Aged; CD18 Antigens; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Macrophage-1 Antigen; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Recombinant Proteins; Stimulation, Chemical; Up-Regulation | 1997 |
1 other study(ies) available for n-formylmethionine leucyl-phenylalanine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Oxidative burst measurement in patients treated with cytostatics: influence of G-CSF and role as a prognostic factor.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Escherichia coli; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Prognosis; Respiratory Burst; Tetradecanoylphorbol Acetate | 2000 |